Literature DB >> 27010173

Leveling of Tuberculosis Incidence - United States, 2013-2015.

Jorge L Salinas, Godwin Mindra, Maryam B Haddad, Robert Pratt, Sandy F Price, Adam J Langer.   

Abstract

After 2 decades of progress toward tuberculosis (TB) elimination with annual decreases of ≥0.2 cases per 100,000 persons (1), TB incidence in the United States remained approximately 3.0 cases per 100,000 persons during 2013-2015. Preliminary data reported to the National Tuberculosis Surveillance System indicate that TB incidence among foreign-born persons in the United States (15.1 cases per 100,000) has remained approximately 13 times the incidence among U.S.-born persons (1.2 cases per 100,000). Resuming progress toward TB elimination in the United States will require intensification of efforts both in the United States and globally, including increasing U.S. efforts to detect and treat latent TB infection, strengthening systems to interrupt TB transmission in the United States and globally, accelerating reductions in TB globally, particularly in the countries of origin for most U.S.

Entities:  

Mesh:

Year:  2016        PMID: 27010173     DOI: 10.15585/mmwr.mm6511a2

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  50 in total

1.  Current and future trends in tuberculosis incidence in New York City: a dynamic modelling analysis.

Authors:  Anthony T Fojo; Natalie L Stennis; Andrew S Azman; Emily A Kendall; Sourya Shrestha; Shama D Ahuja; David W Dowdy
Journal:  Lancet Public Health       Date:  2017-07

2.  Trends in Testing for Mycobacterium tuberculosis Complex From US Public Health Laboratories, 2009-2013.

Authors:  Frances Tyrrell; Cortney Stafford; Mitchell Yakrus; Monica Youngblood; Andrew Hill; Stephanie Johnston
Journal:  Public Health Rep       Date:  2016-12-12       Impact factor: 2.792

3.  Transmission of Extensively Drug-Resistant Tuberculosis in South Africa.

Authors:  N Sarita Shah; Sara C Auld; James C M Brust; Barun Mathema; Nazir Ismail; Pravi Moodley; Koleka Mlisana; Salim Allana; Angela Campbell; Thuli Mthiyane; Natashia Morris; Primrose Mpangase; Hermina van der Meulen; Shaheed V Omar; Tyler S Brown; Apurva Narechania; Elena Shaskina; Thandi Kapwata; Barry Kreiswirth; Neel R Gandhi
Journal:  N Engl J Med       Date:  2017-01-19       Impact factor: 91.245

4.  Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.

Authors:  J W Adams; C J Howe; A C Andrews; S L Allen; C Vinnard
Journal:  AIDS Care       Date:  2017-05-09

5.  Screening for Latent Tuberculosis Infection Among HIV-Infected Medicaid Enrollees.

Authors:  Eleanor E Friedman; Awal Khan; Wayne A Duffus
Journal:  Public Health Rep       Date:  2018-06-21       Impact factor: 2.792

Review 6.  Latent tuberculosis infection: the final frontier of tuberculosis elimination in the USA.

Authors:  Philip A LoBue; Jonathan H Mermin
Journal:  Lancet Infect Dis       Date:  2017-05-08       Impact factor: 25.071

7.  Comparing Drivers and Dynamics of Tuberculosis in California, Florida, New York, and Texas.

Authors:  Sourya Shrestha; Andrew N Hill; Suzanne M Marks; David W Dowdy
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

8.  Sustainability of a Tuberculosis Screening Program at an Adult Education Center Through Community-Based Participatory Research.

Authors:  Mark L Wieland; Julie A Nigon; Jennifer A Weis; Leah Espinda-Brandt; Dawn Beck; Irene G Sia
Journal:  J Public Health Manag Pract       Date:  2019 Nov/Dec

9.  Believability of new diseases reported in the 2014 Surgeon General's Report on smoking: Experimental results from a national survey of US adults.

Authors:  Diane B Francis; Seth M Noar; Sarah D Kowitt; Kristen L Jarman; Adam O Goldstein
Journal:  Prev Med       Date:  2017-02-09       Impact factor: 4.018

10.  Prospects for Tuberculosis Elimination in the United States: Results of a Transmission Dynamic Model.

Authors:  Nicolas A Menzies; Ted Cohen; Andrew N Hill; Reza Yaesoubi; Kara Galer; Emory Wolf; Suzanne M Marks; Joshua A Salomon
Journal:  Am J Epidemiol       Date:  2018-09-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.